Deutsch English Français

Contact

EP1542685

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1542685

EP1542685 - TRIAZOLE DERIVATIVES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.06.2009 Database last updated on 11.09.2024
Most recent event Tooltip	19.06.2009	Application deemed to be withdrawn	published on 22.07.2009 [2009/30]
Applicant(s)	For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US
	[N/P]
Former [2005/25]	For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US
Inventor(s)	01 / BLUMBERG, Laura Cook 5 Division Street, Waterford Connecticut 06385 / US
	02 / MUNCHHOF, Michael John 266 West Road, Salem Connecticut 06420 / US
	[2005/25]
Representative(s)	Hayles, James Richard, et al Pfizer ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
	[N/P]
Former [2009/26]	Hayles, James Richard, et al Pfizer Limited Patents Department Ramsgate Road Sandwich Kent CT13 9NJ / GB
Former [2006/21]	Hayles, James Richard, et al Pfizer Limited European Pharma Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB
Former [2005/25]	Tesch, Rudolf, Dr., et al c/o Pfizer GmbH, Arzneimittelwerk Gödecke Mooswaldallee 1 79090 Freiburg / DE
Application number, filing date	03797428.4	08.09.2003
	[2005/25]
	WO2003IB03825
Priority number, date	US20020412079P	18.09.2002 Original published format: US 412079 P
	US20030484535P	02.07.2003 Original published format: US 484535 P
	[2005/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004026307
	Date:	01.04.2004
	Language:	EN
	[2004/14]
	Type:	A1 Application with search report
	No.:	EP1542685
	Date:	22.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.04.2004 takes the place of the publication of the European patent application.
	[2005/25]
Search report(s)	International search report - published on:	EP	01.04.2004
Classification	IPC:	A61K31/444, C07D471/04, C07D401/14, A61P35/00	[2005/25]
	CPC:	C07D471/04 (EP,KR,US); C07D401/14 (EP,KR,US); A61K31/444 (KR); A61P1/16 (EP); A61P13/12 (EP); A61P17/00 (EP); (+) A61P3/10 (EP); A61P35/00 (EP); A61P9/00 (EP); C07D413/14 (KR) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/25]
Extension states	AL	18.04.2005
	LT	18.04.2005
	LV	18.04.2005
	MK	18.04.2005
Title	German:	NEUE TRIAZOL- UND OXAZOLVERBINDUNGEN ALS INHIBITOREN DES TRANSFORMING GROWTH FACTORS (TGF)	[2005/25]
	English:	TRIAZOLE DERIVATIVES AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS	[2005/25]
	French:	DERIVES DE TRIAZOLE SERVANT D'INHIBITEURS DU FACTEUR DE CROISSANCE TRANSFORMANT (TGF)	[2005/25]
Entry into regional phase	18.04.2005	National basic fee paid
	18.04.2005	Designation fee(s) paid
	18.04.2005	Examination fee paid
Examination procedure	06.10.2003	Request for preliminary examination filed International Preliminary Examining Authority: EP
	09.03.2005	Amendment by applicant (claims and/or description)
	18.04.2005	Examination requested [2005/25]
	07.09.2005	Despatch of a communication from the examining division (Time limit: M06)
	13.03.2006	Reply to a communication from the examining division
	05.04.2007	Despatch of a communication from the examining division (Time limit: M06)
	20.12.2007	Reply to a communication from the examining division
	18.09.2008	Despatch of a communication from the examining division (Time limit: M04)
	29.01.2009	Application deemed to be withdrawn, date of legal effect [2009/30]
	06.03.2009	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/30]
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	20.12.2007	Request for further processing filed
	20.12.2007	Full payment received (date of receipt of payment) Request granted
	03.03.2008	Decision despatched
Fees paid	Renewal fee
	05.09.2005	Renewal fee patent year 03
	02.10.2006	Renewal fee patent year 04
	01.10.2007	Renewal fee patent year 05
	30.09.2008	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]JPS6058981 ;
		[X]JP2000302680 ;
		[X]EP0149884 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1,11 * page 1, 1st paragraph; Caplus RN: 97422-31-6, 97422-41-8, 97422-42-9, 97422-43-0 *;
		[X]WO9315071 (SMITHKLINE BEECHAM INTERCREDIT [NL]) [X] 1,11 * Caplus-RN:151103-24-1, 1511-0-25-2, 151103-28-5, 151103-21-8, 151103-22-9, 151103-26-3, 151103-27-4, 151103-29-6, 151103-30-9, 151103-31-0, 151103-33-2, 151103-35-4; page 1, line 3 - page 1, line 7 *;
		[X]EP1205478 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1,11 * Caplus-RN: 97422-31-6,97422-41-8,97422-42-9, 97422-43-0, 223914-58-7; page 2, line 5 - page 2, line 9 *;
		[X]WO02051442 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al) [X] 1,11* Caplus-RN: 97422-31-6, 97422-41-8, 97422-42-9, 97422-43-0, 223914-58-7 *;
		[X]WO02062753 (GLAXO GROUP LTD [GB], et al) [X] 1-13 * assays 1,2; page 1, line 3 - page 1, line 6; examples 1-6; claims 1-11 *;
		[X]WO02062793 (GLAXO GROUP LTD [GB], et al) [X] 1-13 * page 1, line 3 - page 1, line 6; examples 1-3; claims 1-11 *;
		[X]WO02062776 (GLAXO GROUP LTD [GB], et al) [X] 1-13 * page 1, line 3 - page 1, line 6; examples 1-3; claims 1-11 *;
		[X]WO02062775 (YAMANOUCHI PHARMA CO LTD [JP], et al) [X] 1,11 * abstract; Caplus-RN: 446066-02-0, 446065-54-9 *;
		[X]US6436966 (OHKAWA SHIGENORI [JP], et al) [X] 1,11 * Caplus-RN:97422-31-6, 97422-41-8, 97422-42-9, 97422-43-0, 223914-58-7; column 1, line 7 - column 1, line 11; example - *;
		[PX]WO02100433 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al) [PX] 1,11 * abstract *
		[X] - PATENT ABSTRACTS OF JAPAN, (19850803), vol. 009, no. 188, Database accession no. (C - 295), & JP60058981 A 19850405 (TAKEDA YAKUHIN KOGYO KK) [X] 1 * abstract *
		[X] - PATENT ABSTRACTS OF JAPAN, (20010205), vol. 2000, no. 13, & JP2000302680 A 20001031 (TAKEDA CHEM IND LTD) [X] 1,11 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p